Dr. Kurth Becomes ASAM President at Annual Business Meeting

Outgoing ASAM President Louis E. Baxter, Sr., M.D., FASAM, (left) passes the presidential gavel to Incoming President Donald J. Kurth, M.D. FASAM, at Friday's Annual Business Meeting

Outgoing ASAM President Louis E. Baxter, Sr., M.D., FASAM, (left) passes the presidential gavel to Incoming President Donald J. Kurth, M.D. FASAM, at Friday’s Annual Business Meeting

Donald J. Kurth, M.D., FASAM, became ASAM President Friday during the Annual Business Meeting. Dr. Kurth began his term by thanking Outgoing President Louis E. Baxter, Sr., M.D., FASAM, for his service to the Society.

Dr. Baxter reflected on his term in office and congratulated Dr. Kurth for the start of his term, and was rewarded by his family with a plaque for his dedication to the family during the last two years even though his duties consumed so much of his time.

The meeting also featured several short speeches and reports:

  • Past President Stanley E. Gitlow, M.D., FASAM, FACP, was honored on the 50th anniversary of his term as ASAM President. His son, President-Elect Stuart Gitlow, M.D., M.P.H., reflected on changes in medicine, from more personal care toward guideline-oriented medicine, “where people will be treated as if on a production line. As to what our future holds as physicians, as addiction specialists, and as an organization, the challenge is clear — we must protect the individuality of our patients, retain our own individuality as physicians, and ensure that our organization always leads the way rather than following unacceptable choices made by others.”
  • Immediate Past President Mike Miller, M.D., FASAM, offered his own going-away comments, which drew a standing ovation from attendees.
  • A new Society Chapter, the Northern New England Chapter, was recognized.
  • A membership report showed a significant increase in membership over 2010.
  • Kevin Kunz, M.D., M.P.H., FASAM, president of the American Board of Addiction Medicine, presented a report that the accreditation of addiction medicine programs and recognition of the field as a specialty is on track.